Arcus Biosciences, Inc. — Director's Dealing 2020

Jan 22, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2020-01-17

Reporting Person: Grossman William (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-17	Stock Option (right to buy)	$10.23	A	140000	Acquired	2029-12-31	Common Stock (140000)	Direct

Footnotes

F1: The option is exercisable in 48 equal monthly installments after January 1, 2020, subject to the Reporting Person's continued service to the Company.